Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/49252, first published .
An eHealth App (CAPABLE) Providing Symptom Monitoring, Well-Being Interventions, and Educational Material for Patients With Melanoma Treated With Immune Checkpoint Inhibitors: Protocol for an Exploratory Intervention Trial

An eHealth App (CAPABLE) Providing Symptom Monitoring, Well-Being Interventions, and Educational Material for Patients With Melanoma Treated With Immune Checkpoint Inhibitors: Protocol for an Exploratory Intervention Trial

An eHealth App (CAPABLE) Providing Symptom Monitoring, Well-Being Interventions, and Educational Material for Patients With Melanoma Treated With Immune Checkpoint Inhibitors: Protocol for an Exploratory Intervention Trial

Journals

  1. Miulescu A, Kozma A, Cucu D. Digital Medicine: from SPA to Medical Recovery. Balneo and PRM Research Journal 2023;14(Vol.14, no. 4):635 View
  2. Glaser S, Fraterman I, van Brummelen N, Tibollo V, Del Campo L, Mallo H, Wilgenhof S, Wilk S, Gisko V, Khadakou V, Cornet R, Ottaviano M, Medlock S. Usability and Usefulness of a Symptom Management Coaching System for Patients With Cancer Treated With Immune Checkpoint Inhibitors: Comparative Mixed Methods Study. JMIR Formative Research 2025;9:e57659 View
  3. Finkelstein J, Smiley A, Echeverria C, Mooney K. AI-Driven Prediction of Symptom Trajectories in Cancer Care: A Deep Learning Approach for Chemotherapy Management. Bioengineering 2024;11(11):1172 View
  4. Fraterman I, Sacchi L, Mallo H, Tibollo V, Glaser S, Medlock S, Cornet R, Gabetta M, Hisko V, Khadakou V, Barkan E, Del Campo L, Glasspool D, Kogan A, Lanzola G, Leizer R, Ottaviano M, Peleg M, Śniatała K, Lisowska A, Wilk S, Parimbelli E, Quaglini S, Rizzo M, Locati L, Boekhout A, van de Poll-Franse L, Wilgenhof S. Exploring the Impact of the Multimodal CAPABLE eHealth Intervention on Health-Related Quality of Life in Patients With Melanoma Undergoing Immune-Checkpoint Inhibition: Prospective Pilot Study. JMIR Cancer 2025;11:e58938 View
  5. Lambert S, Soldera S, Kazdan J, Frati F, Slominska A, Boutin M, Samouelian V, Letendre C, Bilodeau K, Howell D, Breton K, Gratton M. Patient-reported outcome measure (PROM) programs for monitoring symptoms among patients treated with immunotherapy: a scoping review. JNCI Cancer Spectrum 2024;8(6) View
  6. Finkelstein J, Smiley A, Echeverria C, Mooney K. Deep Learning Approaches to Forecast Physical and Mental Deterioration During Chemotherapy in Patients with Cancer. Diagnostics 2025;15(8):956 View